Order intake more than doubled year-over-year, but net sales fell due to prior weak quarters. Cost reductions and improved working capital led to positive operating cash flow, while AMR projects and new orders support a stronger outlook for H2 2024.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.